Utah Medical Products - 41 Year Stock Price History | UTMD
Historical daily share price chart and data for Utah Medical Products since 1984 adjusted for splits and dividends. The latest closing stock price for Utah Medical Products as of April 21, 2025 is 52.50.
- The all-time high Utah Medical Products stock closing price was 116.50 on November 22, 2021.
- The Utah Medical Products 52-week high stock price is 77.33, which is 47.3% above the current share price.
- The Utah Medical Products 52-week low stock price is 51.71, which is 1.5% below the current share price.
- The average Utah Medical Products stock price for the last 52 weeks is 64.30.
| Utah Medical Products Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 58.5540 | 61.0226 | 63.8275 | 52.3000 | 52.5000 | -14.13% |
| 2024 | 67.7196 | 81.5512 | 82.2838 | 60.5750 | 61.1419 | -25.69% |
| 2023 | 87.5306 | 94.2394 | 96.6880 | 75.0237 | 82.2741 | -15.10% |
| 2022 | 85.3421 | 92.3840 | 97.9088 | 77.3246 | 96.9097 | 1.87% |
| 2021 | 84.9999 | 77.4795 | 116.5030 | 76.4741 | 95.1333 | 21.97% |
| 2020 | 80.5197 | 97.5234 | 99.1312 | 70.6072 | 77.9977 | -20.87% |
| 2019 | 83.2003 | 76.5029 | 99.8437 | 70.4037 | 98.5648 | 31.46% |
| 2018 | 84.6083 | 70.7492 | 104.0640 | 67.3608 | 74.9777 | 3.24% |
| 2017 | 61.7069 | 62.7455 | 74.9870 | 51.7167 | 72.6227 | 13.59% |
| 2016 | 54.9196 | 50.7163 | 63.9319 | 47.9929 | 63.9319 | 26.32% |
| 2015 | 48.3710 | 49.1330 | 53.4471 | 43.3601 | 50.6125 | -0.71% |
| 2014 | 44.5184 | 43.1233 | 51.0430 | 39.4103 | 50.9751 | 7.04% |
| 2013 | 41.1494 | 31.2847 | 52.5733 | 31.2847 | 47.6222 | 61.81% |
| 2012 | 26.2361 | 21.6531 | 29.5213 | 21.3914 | 29.4315 | 37.48% |
| 2011 | 20.8512 | 20.6468 | 22.6174 | 19.0962 | 21.4073 | 4.09% |
| 2010 | 20.0608 | 21.3180 | 22.3858 | 17.9314 | 20.5664 | -2.74% |
| 2009 | 18.5059 | 16.6664 | 21.4625 | 14.8385 | 21.1450 | 38.43% |
| 2008 | 18.8639 | 19.9195 | 20.7944 | 14.7249 | 15.2747 | -23.63% |
| 2007 | 21.0503 | 21.5877 | 22.7083 | 19.6516 | 20.0003 | -7.30% |
| 2006 | 20.3948 | 19.5340 | 22.4295 | 18.1934 | 21.5746 | 5.78% |
| 2005 | 14.9047 | 13.8080 | 20.3958 | 12.4962 | 20.3958 | 46.00% |
| 2004 | 14.1559 | 15.6632 | 16.5445 | 10.5762 | 13.9697 | -12.28% |
| 2003 | 12.9130 | 11.7641 | 15.9251 | 10.6614 | 15.9251 | 36.86% |
| 2002 | 9.5548 | 8.0418 | 11.7458 | 7.6397 | 11.6362 | 40.34% |
| 2001 | 6.4210 | 4.5692 | 8.3707 | 4.2836 | 8.2915 | 81.47% |
| 2000 | 4.3711 | 3.9219 | 5.1023 | 3.6553 | 4.5692 | 11.11% |
| 1999 | 4.1580 | 4.0361 | 4.8357 | 3.4269 | 4.1123 | 2.86% |
| 1998 | 4.2303 | 4.3788 | 5.3307 | 3.0842 | 3.9980 | -3.67% |
| 1997 | 5.4851 | 8.3007 | 8.3007 | 4.0361 | 4.1503 | -49.07% |
| 1996 | 8.9511 | 11.4991 | 13.2506 | 6.8538 | 8.1484 | -32.49% |
| 1995 | 7.6774 | 5.2546 | 12.5652 | 5.2546 | 12.0703 | 133.09% |
| 1994 | 4.9135 | 4.7976 | 5.9399 | 3.8838 | 5.1784 | 7.94% |
| 1993 | 5.8471 | 7.2118 | 8.6743 | 4.5692 | 4.7976 | -34.84% |
| 1992 | 6.4150 | 9.0777 | 9.8847 | 4.3371 | 7.3631 | -23.96% |
| 1991 | 7.2845 | 4.6397 | 9.6829 | 4.2363 | 9.6829 | 108.70% |
| 1990 | 3.8563 | 4.0346 | 5.5475 | 3.1772 | 4.6397 | 19.48% |
| 1989 | 2.0284 | 1.0720 | 4.3371 | 1.0215 | 3.8833 | 262.25% |
| 1988 | 0.8136 | 0.5677 | 1.0969 | 0.5047 | 1.0720 | 84.83% |
| 1987 | 0.6879 | 0.7439 | 0.8577 | 0.4039 | 0.5800 | -22.03% |
| 1986 | 0.7998 | 1.0843 | 1.1347 | 0.6304 | 0.7439 | -31.39% |
| 1985 | 1.0921 | 0.6685 | 1.4125 | 0.6304 | 1.0843 | 62.20% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.172B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |